BTIG Research Issues Pessimistic Forecast for OrthoPediatrics (NASDAQ:KIDS) Stock Price

Key Points

• BTIG Research has reduced the price target for OrthoPediatrics (NASDAQ:KIDS) from $40.00 to $39.00, while maintaining a "buy" rating, indicating a potential upside of 121.15% from the stock's previous close.
• OrthoPediatrics shares have experienced a significant drop of 12.7% during trading, closing at $17.64, compared to a 12-month high of $33.14.
• Currently, equities analysts show a mixed outlook on the stock, with one "sell," one "hold," and six "buy" ratings, leading to an average rating of "Moderate Buy".

OrthoPediatrics (NASDAQ:KIDS - Free Report) had its target price lowered by BTIG Research from $40.00 to $39.00 in a research note released on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.

Other equities analysts have also issued research reports about the stock. Wall Street Zen lowered shares of OrthoPediatrics from a "hold" rating to a "sell" rating in a report on Friday, July 18th. Needham & Company LLC restated a "buy" rating and issued a $42.00 target price on shares of OrthoPediatrics in a report on Thursday, May 8th. Piper Sandler lowered their target price on shares of OrthoPediatrics from $40.00 to $30.00 and set an "overweight" rating on the stock in a report on Thursday, May 8th. Finally, Truist Financial reduced their price objective on shares of OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating for the company in a research report on Friday, April 11th. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $34.14.

OrthoPediatrics Stock Performance

Shares of NASDAQ:KIDS traded down $0.29 on Wednesday, reaching $18.91. 157,582 shares of the company's stock were exchanged, compared to its average volume of 190,318. The company has a fifty day moving average of $21.38 and a 200-day moving average of $22.58. OrthoPediatrics has a twelve month low of $16.59 and a twelve month high of $33.14. The company has a market capitalization of $474.07 million, a price-to-earnings ratio of -10.56 and a beta of 1.12. The company has a current ratio of 6.66, a quick ratio of 3.43 and a debt-to-equity ratio of 0.27.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.17) by $0.06. OrthoPediatrics had a negative net margin of 18.92% and a negative return on equity of 6.36%. The business had revenue of $61.08 million for the quarter, compared to analyst estimates of $61.40 million. On average, research analysts predict that OrthoPediatrics will post -0.93 EPS for the current fiscal year.

Institutional Trading of OrthoPediatrics

A number of institutional investors have recently modified their holdings of the business. KLP Kapitalforvaltning AS purchased a new stake in OrthoPediatrics in the 4th quarter worth approximately $79,000. Wells Fargo & Company MN lifted its stake in OrthoPediatrics by 31.1% in the 4th quarter. Wells Fargo & Company MN now owns 9,853 shares of the company's stock worth $228,000 after purchasing an additional 2,338 shares in the last quarter. PDT Partners LLC purchased a new stake in shares of OrthoPediatrics during the 1st quarter valued at $244,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of OrthoPediatrics by 6.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,995 shares of the company's stock valued at $246,000 after buying an additional 645 shares in the last quarter. Finally, Los Angeles Capital Management LLC purchased a new stake in shares of OrthoPediatrics during the 2nd quarter valued at $220,000. 69.05% of the stock is currently owned by hedge funds and other institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.